Vertex Pharmaceuticals (VRTX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $989.9 million.
- Vertex Pharmaceuticals' Other Gross PP&E Adjustments rose 2829.19% to $989.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $989.9 million, marking a year-over-year increase of 2829.19%. This contributed to the annual value of $989.9 million for FY2025, which is 2829.19% up from last year.
- Vertex Pharmaceuticals' Other Gross PP&E Adjustments amounted to $989.9 million in Q4 2025, which was up 2829.19% from -$1.6 billion recorded in Q3 2025.
- Vertex Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $1.9 billion for Q4 2023, and its period low was -$1.6 billion during Q3 2025.
- For the 5-year period, Vertex Pharmaceuticals' Other Gross PP&E Adjustments averaged around -$130.2 million, with its median value being -$320.3 million (2021).
- Per our database at Business Quant, Vertex Pharmaceuticals' Other Gross PP&E Adjustments tumbled by 34962.96% in 2024 and then skyrocketed by 2829.19% in 2025.
- Over the past 5 years, Vertex Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $1.5 billion in 2021, then grew by 11.27% to $1.7 billion in 2022, then grew by 14.82% to $1.9 billion in 2023, then plummeted by 59.61% to $771.6 million in 2024, then grew by 28.29% to $989.9 million in 2025.
- Its Other Gross PP&E Adjustments stands at $989.9 million for Q4 2025, versus -$1.6 billion for Q3 2025 and -$1.3 billion for Q2 2025.